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Abstract
The COVID-19 pandemic continues to have a tremendous impact
on patients and healthcare systems around the world. To combat
this disease, there is a need for effective screening tools to identify
patients infected with COVID-19, and to this end CT imaging has
been proposed as a key screening method to complement RT-PCR
testing. Early studies have reported abnormalities in chest CT im-
ages which are characteristic of COVID-19 infection, but these ab-
normalities may be difficult to distinguish from abnormalities caused
by other lung conditions. Motivated by this, we introduce COVIDNet-
CT, a deep convolutional neural network architecture tailored for
detection of COVID-19 cases from chest CT images. We also in-
troduce COVIDx-CT, a CT image dataset comprising 104,009 im-
ages across 1,489 patient cases. Finally, we leverage explainability
to investigate the decision-making behaviour of COVIDNet-CT and
ensure that COVIDNet-CT makes predictions based on relevant in-
dicators in CT images.
1 Introduction
Currently, real-time reverse transcription polymerase chain reaction
(RT-PCR) testing is the primary means of screening for COVID-19,
as it can detect SARS-CoV-2 ribonucleic acid (RNA) in sputum sam-
ples collected from the upper respiratory tract [1]. While RT-PCR
testing for COVID-19 is highly specific, its sensitivity is variable de-
pending on sampling method and time since onset of symptoms [2–
4], and some studies have reported relatively low COVID-19 sensi-
tivity [3, 5].
Chest computed tomography (CT) imaging has been proposed
as an effective screening tool for COVID-19 infection due to its high
sensitivity, particularly when used as a complement to RT-PCR test-
ing [4–6]. In early studies, it was found that certain abnormalities in
chest CT images are indicative of COVID-19 infection [4–10]. How-
ever, these imaging abnormalities may not be specific to COVID-
19 infection, and the performance of radiologists in distinguishing
COVID-19-related abnormalities from abnormalities of other etiol-
ogy may vary considerably [11, 12].
In this study, we introduce COVIDNet-CT, a deep convolu-
tional neural network architecture tailored specifically for detection
of COVID-19 cases from chest CT images via a machine-driven de-
sign exploration approach. We also introduce COVIDx-CT, a bench-
mark CT image dataset derived from CT imaging data collected by
the China National Center for Bioinformation (CNCB) [13] compris-
ing 104,009 images across 1,489 patient cases. Additionally, to in-
vestigate the decision-making behaviour of COVIDNet-CT, we per-
form an explainability-driven performance validation and analysis of
its predictions, allowing us to explore the critical factors associated
with COVID-19 infection while also auditing COVIDNet-CT to en-
sure that its decisions are based on relevant CT image features.
2 Methods
2.1 COVIDx-CT dataset
To build the proposed COVIDNet-CT, we constructed a dataset of
104,009 chest CT images across 1,489 patient cases, which we re-
fer to as COVIDx-CT. This dataset is derived from CT imaging data
collected by the CNCB [13], which is comprised of chest CT vol-
umes across three different infection types: novel coronavirus pneu-
monia due to SARS-CoV-2 viral infection (NCP), common pneumo-
nia (CP), and normal controls. For NCP and CP CT volumes, slices
marked as containing lung abnormalities were leveraged. We split
the COVIDx-CT dataset into training, validation, and test sets, us-
ing an approximate 60%-20%-20% split for training, validation, and
test, respectively.
2.2 Machine-driven design exploration
Inspired by [14], in this study we leveraged generative synthesis [15]
as our machine-driven design exploration strategy, where the prob-
lem of identifying a tailored deep neural network architecture for the
task and data at hand is formulated as a constrained optimization
problem based on a universal performance function U (e.g., [16])
and a set of quantitative constraints. For the initial network de-
sign prototype, we leveraged residual architecture design princi-
ples [17, 18], as they have been shown to enable reliable deep
architectures which are easier to train to high performance.
2.3 Network architecture
The proposed COVIDNet-CT architecture is shown in Figure 1, and
is made publicly available1. As can be seen, the machine-driven de-
sign exploration strategy made heavy use of unstrided and strided
projection-replication-projection-expansion design patterns (which
we denote as PRPE and PRPE-S for unstrided and strided patterns
respectively) consisting of a projection to lower channel dimension-
ality via pointwise convolutions, a replication of the projections to
increase channel dimensionality efficiently, an efficient spatial fea-
ture representation via depthwise convolutions, a projection to lower
channel dimensionality via pointwise convolutions, and finally an ex-
pansion of channel dimensionality conducted by pointwise convolu-
tions. Selective long-range connectivity can also be observed in the
proposed COVIDNet-CT architecture, which enables greater rep-
resentational capabilities in a more efficient manner than densely-
connected deep neural network architectures.
Fig. 1: The proposed COVIDNet-CT architecture designed via
machine-driven design exploration. Notable characteristics include
high architectural diversity, selective long-range connectivity, and
lightweight design patterns (e.g., PRPE and PRPE-S patterns).
2.4 Explainability-driven performance validation of
COVIDNet-CT
In clinical applications, the ability to understand how a deep neu-
ral network makes decisions is critical, as these decisions may
ultimately affect the health of patients. Motivated by this, we au-
dit COVIDNet-CT via an explainability-driven performance analy-
sis strategy in order to better understand which CT imaging fea-
tures are critical to its detection decisions. In this study, we
leverage GSInquire [19] as the explainability method of choice for
explainability-driven performance validation to visualize critical fac-
tors in CT images. GSInquire leverages the generative synthesis
strategy [15] that was employed for machine-driven design explo-
ration, and was previously shown quantitatively to provide explana-
tions that better reflect the decision-making process of deep neu-
1https://github.com/haydengunraj/COVIDNet-CT
ral networks when compared to other state-of-the-art explainability
methods [19].
3 Results and discussion
3.1 Quantitative results
We quantitatively evaluate the performance of the proposed
COVIDNet-CT on the COVIDx-CT dataset. The test accuracy, ar-
chitectural complexity, and computational complexity of COVIDNet-
CT are shown in Table 1. As shown, COVIDNet-CT achieves a
relatively high test accuracy of 99.1%, which is 0.4% higher than
that achieved with the ResNet-50 architecture [18] and 0.8% higher
than that achieved with the EfficientNet-B0 architecture [20]. More-
over, COVIDNet-CT has significantly lower architectural and compu-
tational complexity than ResNet-50 (94.1% fewer parameters and
90.2% fewer FLOPs), and compared to EfficientNet-B0 it exhibits
reduced architectural complexity and similar computational com-
plexity. From Table 2, we observe that COVIDNet-CT achieves good
COVID-19 sensitivity (97.3%), which ensures a low proportion of
false-negatives for COVID-19 cases. Moreover, given that RT-PCR
testing is highly specific, COVIDNet-CT’s high sensitivity would al-
low it to effectively complement RT-PCR testing. Next, from Ta-
ble 3, we observe that COVIDNet-CT also achieves a high COVID-
19 PPV, thereby ensuring a low proportion of false-positives which
could cause an unnecessary burden on the healthcare system in
the form of isolation, testing, and treatment. Based on these re-
sults, it is shown that COVIDNet-CT could be used as an effective
standalone screening tool for COVID-19 patients, and could also be
used in conjunction with RT-PCR testing.
Table 1: Comparison of parameters, FLOPs, and accuracy (image-
level) for tested network architectures on the COVIDx-CT dataset.
Best results highlighted in bold.
Architecture Param. (M) FLOPs (G) Accuracy (%)
ResNet-50 [18] 23.55 42.72 98.7
EfficientNet-B0 [20] 4.05 4.07 98.3
COVIDNet-CT 1.40 4.18 99.1
Table 2: Sensitivity for each infection type at the image level on the
COVIDx-CT dataset. Best results highlighted in bold.
Sensitivity (%)
Architecture Normal Non-COVID-19 COVID-19
ResNet-50 [18] 99.9 98.7 96.2
EfficientNet-B0 [20] 99.8 97.8 95.8
COVIDNet-CT 100.0 99.0 97.3
Table 3: Positive predictive value (PPV) for each infection type at
the image level on the COVIDx-CT dataset. Best results highlighted
in bold.
PPV (%)
Architecture Normal Non-COVID-19 COVID-19
ResNet-50 [18] 99.3 97.8 99.1
EfficientNet-B0 [20] 98.7 97.6 98.6
COVIDNet-CT 99.4 98.4 99.7
3.2 Qualitative results
In this study, we leveraged GSInquire [19] to perform explainability-
driven performance validation of COVIDNet-CT in order to better
understand its decision-making behaviour, and to ensure that its de-
cisions are based on diagnostically-relevant imaging features rather
than irrelevant visual indicators. As previously mentioned, GSIn-
quire leverages the generative synthesis strategy in order to identify
the critical factors leveraged by COVIDNet-CT to make its detection
decisions. Figure 2 shows the critical factors identified by GSInquire
for three chest CT images of patients with COVID-19 pneumonia.
Examining these visual interpretations, we observe that COVIDNet-
CT primarily leverages abnormalities within the lungs in the chest
CT images to identify COVID-19 cases, as well as to differentiate
these cases from non-COVID-19 pneumonia cases. As previously
mentioned, our initial experiments yielded deep neural networks
that were found via explainability-driven performance validation to
be basing their detection decisions on irrelevant indicators such as
patient tables and imaging artifacts, which highlights the importance
of leveraging explainability methods when building and evaluating
deep neural networks for clinical applications.
Fig. 2: Example chest CT images of COVID-19 cases and their
associated critical factors (highlighted in red) as identified by GSIn-
quire [19].
Based on both quantitative and qualitative results, it can be seen
that not only does COVIDNet-CT achieve high performance, but it is
leveraging relevant abnormalities in the lungs in its decision-making
process rather than erroneous visual cues.
4 Conclusion
In this study, we introduced COVIDNet-CT, a deep convolutional
neural network architecture tailored for detection of COVID-19
cases from chest CT images via machine-driven design explo-
ration. Additionally, we introduced COVIDx-CT, a benchmark CT
image dataset consisting of 104,009 chest CT images across 1,489
patients. We quantitatively evaluated COVIDNet-CT using the
COVIDx-CT test dataset in terms of accuracy, sensitivity, and PPV.
Furthermore, we analysed the predictions of COVIDNet-CT via
explainability-driven performance validation to ensure that its pre-
dictions are based on relevant image features and to better under-
stand the CT image features associated with COVID-19 infection. In
our analyses, we observed that COVIDNet-CT is highly performant
when tested on the COVIDx-CT test dataset, and that abnormalities
in the lungs are leveraged by COVIDNet-CT in its decision-making
process.
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